Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004705 · ClinicalTrials.gov registry record · Phase 2
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
A Phase 2 study, sponsored by Ferrer Internacional S.A..
- Terminated
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT01004705 is a Phase 2 study that was terminated before completion, run by Ferrer Internacional S.A.. The registered enrollment target is 36 participants.
The verdict
NCT01004705, a Phase 2 study, was terminated before completion, sponsored by Ferrer Internacional S.A..
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study evaluates the effect on LDL cholesterol of the 3 drugs given together in the cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin, and ramipril) as compared to the effect on LDL cholesterol of simvastatin given alone. Approximately 76 subjects will be screened, 60 randomized in order about 52 subjects to finish the study.
Interventions
- DRUG Simvastatin
- DRUG Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01004705
The ClinicalTrials.gov registry entry for NCT01004705 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferrer Internacional S.A., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Simvastatin is the first listed.
NCT01004705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01004705 about?
NCT01004705 is a clinical study titled "A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol". This study evaluates the effect on LDL cholesterol of the 3 drugs given together in the cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin, and ramipril) as compared to the effect on LDL cholesterol of simvastatin given alone. Approximately 76 subjects will be screened, 60...
What is the current status of trial NCT01004705?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2009-09. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01004705?
The interventions under investigation include: Simvastatin (DRUG), Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril), (DRUG).
Who is sponsoring clinical trial NCT01004705?
This trial is sponsored by Ferrer Internacional S.A., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.